Summit buys microkeratome from EyeTech Vision
This article was originally published in Clinica
Ophthalmic laser company Summit Technology has bought the Krumeich-Barraquer microkeratome from EyeTech Vision, which is based in Liechtenstein and the US, for an undisclosed sum. Summit will begin selling the high precision, corneal surgical device to international customers immediately. The Waltham, Massachusetts-based company will commence sales in the US upon receipt of FDA 510(k) clearance.
The device, which is used by around 25 surgeons in 14 countries worldwide, is the only system with computer-controlled critical surgical parameters, the company says. In addition, it can be customised and has an adjustable oscillation speed. The translation speed is controlled by the surgeon.
"We undertook an extensive review of the microkeratome technologies available today and made the decision that the Krumeich-Barraquer system provides surgeons with the most advanced features available in any microkeratome system on the market," said Summit's CEO, Robert Palmisano.